Research Project
Project Title: |
A Phase II, randomised, open-label, multicentre study to assess the reactogenicity, safety and immunogenicity of GSK's paediatric Herpes Zoster subunit candidate vaccine (PED-HZ/su) when administered intramuscularly on a two-dose schedule to immunocomprom |
Project Type: |
Clinical Trial, Enrolment ongoing |
Disease group(s): |
Pediatric kidney transplantation |
Project Summary: |
A Phase II, randomised, open-label, multicentre study to assess the reactogenicity, safety and immunogenicity of GSK's paediatric Herpes Zoster subunit candidate vaccine (PED-HZ/su) when administered intramuscularly on a two-dose schedule to immunocompromised paediatric renal transplant recipients from 1 to 17 years of age. |
Lead principal investigator(s): |
Giovanni Montini, Milan |
Project Period: |
09/2019 - 09/2050 |
EudraCT Nr.: |
2019-000607-33 |
« Back to research page